• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

还原酶不稳定肽超分子水凝胶辅助益生菌经口递送。

Reductase-Labile Peptidic Supramolecular Hydrogels Aided in Oral Delivery of Probiotics.

机构信息

Beijing Laboratory of Biomedical Materials, College of Materials Science and Engineering, Beijing University of Chemical Technology, Beijing 100029, China.

CAS Key Laboratory of Biomedical Effects of Nanomaterials and Nanosafety, National Center for Nanoscience and Technology, Beijing 100190, China.

出版信息

ACS Appl Mater Interfaces. 2023 Jul 5;15(26):31214-31223. doi: 10.1021/acsami.3c04408. Epub 2023 Jun 20.

DOI:10.1021/acsami.3c04408
PMID:37339324
Abstract

Oral delivery of probiotics has been a promising method for treatment of inflammatory bowel diseases (IBDs). However, probiotics always suffer from substantial loss of viability due to the harsh gastrointestinal conditions, especially the highly acidic environment in the stomach and bile salts in the intestine. In addition, to overcome the challenging conditions, an ideal delivery of probiotics requires the on-demand release of probiotics upon environmental response. Herein, a novel nitroreductase (NTR) labile peptidic hydrogel based on supramolecular self-assembly is demonstrated. The efficient encapsulation of typical probiotic (EcN) into supramolecular assemblies yielded a probiotic-loaded hydrogel (EcN@Gel). Such a hydrogel adequately protected EcN to improve its viability against harsh acid and bile salt environments during oral delivery. The upregulated NTR in the intestinal tract triggered the disassembly of the hydrogel and accomplished the controlled release of EcN locally. In ulcerative colitis (UC)-bearing mice, EcN@Gel showed significantly enhanced therapeutic efficacy by downregulating proinflammatory cytokines and repairing the intestinal barrier. Moreover, EcN@Gel remolded the gut microbiome by increasing the diversity and abundance of indigenous probiotics, contributing to ameliorated therapies of IBDs. The NTR-labile hydrogel provided a promising platform for the on-demand delivery of probiotics into the intestinal tract.

摘要

口服递送益生菌一直是治疗炎症性肠病(IBD)的一种很有前景的方法。然而,由于胃肠道环境恶劣,特别是胃酸和肠道胆汁盐的存在,益生菌的存活率往往会受到很大的影响。此外,为了克服这些挑战性的条件,理想的益生菌递送需要在环境响应时按需释放益生菌。本文中,作者展示了一种基于超分子自组装的新型硝基还原酶(NTR)不稳定肽类水凝胶。典型益生菌(EcN)的高效包封到超分子组装体中,得到了负载益生菌的水凝胶(EcN@Gel)。这种水凝胶能够充分保护 EcN,提高其在口服递送过程中抵抗恶劣酸和胆汁盐环境的生存能力。肠道中上调的 NTR 触发水凝胶的解组装,并实现 EcN 的局部控制释放。在溃疡性结肠炎(UC)荷瘤小鼠中,EcN@Gel 通过下调促炎细胞因子和修复肠道屏障,显示出显著增强的治疗效果。此外,EcN@Gel 通过增加本土益生菌的多样性和丰度来重塑肠道微生物组,有助于改善 IBD 的治疗效果。NTR 不稳定水凝胶为益生菌按需递送到肠道提供了一个很有前途的平台。

相似文献

1
Reductase-Labile Peptidic Supramolecular Hydrogels Aided in Oral Delivery of Probiotics.还原酶不稳定肽超分子水凝胶辅助益生菌经口递送。
ACS Appl Mater Interfaces. 2023 Jul 5;15(26):31214-31223. doi: 10.1021/acsami.3c04408. Epub 2023 Jun 20.
2
Oral nanozyme-engineered probiotics for the treatment of ulcerative colitis.口服纳米酶工程益生菌治疗溃疡性结肠炎。
J Mater Chem B. 2022 Jun 1;10(21):4002-4011. doi: 10.1039/d2tb00300g.
3
Beneficial effects resulting from oral administration of Nissle 1917 on a chronic colitis model.口服 1917 号奈瑟氏菌对慢性结肠炎模型的有益作用。
Benef Microbes. 2020 Dec 2;11(8):779-790. doi: 10.3920/BM2020.0045. Epub 2020 Nov 16.
4
Breaking barriers: bacterial-microalgae symbiotic systems as a probiotic delivery system.突破障碍:细菌-微藻共生系统作为益生菌输送系统。
J Nanobiotechnology. 2024 Jun 25;22(1):371. doi: 10.1186/s12951-024-02647-6.
5
Microfluidics-Derived Microparticles with Prebiotics and Probiotics for Enhanced In Situ Colonization and Immunoregulation of Colitis.基于微流控技术的益生菌和益生元衍生微球用于增强结肠炎的原位定植和免疫调节。
Nano Lett. 2024 Jan 31;24(4):1081-1089. doi: 10.1021/acs.nanolett.3c03580. Epub 2024 Jan 16.
6
Modified Prebiotic-Based "Shield" Armed Probiotics with Enhanced Resistance of Gastrointestinal Stresses and Prolonged Intestinal Retention for Synergistic Alleviation of Colitis.基于改性益生元的“盾牌”武装益生菌,具有增强的胃肠道应激抗性和延长的肠道保留时间,可协同缓解结肠炎。
ACS Nano. 2023 Aug 8;17(15):14775-14791. doi: 10.1021/acsnano.3c02914. Epub 2023 Jul 21.
7
Metal-Phenolic Network Directed Coating of Single Probiotic Cell Followed by Photoinitiated Thiol-Ene Click Fortification to Enhance Oral Therapy.金属-酚醛网络引导的单益生菌细胞包被,随后进行光引发硫醇-烯点击加固,以增强口服治疗。
Small. 2024 May;20(19):e2308146. doi: 10.1002/smll.202308146. Epub 2023 Dec 6.
8
Modified montmorillonite armed probiotics with enhanced on-site mucus-depleted intestinal colonization and HS scavenging for colitis treatment.改性蒙脱石负载益生菌增强定植于黏液缺失肠道并高效清除活性氧用于结肠炎治疗
J Control Release. 2024 Oct;374:140-153. doi: 10.1016/j.jconrel.2024.07.071. Epub 2024 Aug 14.
9
Encapsulation of Escherichia coli strain Nissle 1917 in a chitosan-alginate matrix by combining layer-by-layer assembly with CaCl cross-linking for an effective treatment of inflammatory bowel diseases.利用层层组装结合 CaCl2 交联技术,将大肠杆菌菌株 Nissle 1917 包封在壳聚糖-海藻酸钠基质中,用于有效治疗炎症性肠病。
Colloids Surf B Biointerfaces. 2020 May;189:110818. doi: 10.1016/j.colsurfb.2020.110818. Epub 2020 Jan 21.
10
Probiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity.益生菌大肠杆菌Nissle 1917通过增强黏膜完整性来抑制肠道渗漏。
PLoS One. 2007 Dec 12;2(12):e1308. doi: 10.1371/journal.pone.0001308.

引用本文的文献

1
Multi-Functional Applications of Hydrogel Delivery Systems in Inflammatory Bowel Disease: Drug Delivery, Anti-Inflammation, and Intestinal Repair.水凝胶递送系统在炎症性肠病中的多功能应用:药物递送、抗炎和肠道修复
Polymers (Basel). 2025 May 22;17(11):1430. doi: 10.3390/polym17111430.
2
Modified probiotics and the related combinatorial therapeutics.改良益生菌及相关联合疗法。
Acta Pharm Sin B. 2025 May;15(5):2431-2453. doi: 10.1016/j.apsb.2025.03.021. Epub 2025 Mar 14.
3
Recent Progress of Oral Functional Nanomaterials for Intestinal Microbiota Regulation.
用于肠道微生物群调节的口腔功能纳米材料的最新进展
Pharmaceutics. 2024 Jul 10;16(7):921. doi: 10.3390/pharmaceutics16070921.